ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Operating income 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) annual operating income history from SEC filings — each fiscal year as reported.
$98.3MFY2025 · since FY2016: -$81.7M → $98.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $98.3M | +116.4% |
| FY2024 | -$601.1M | -193.2% |
| FY2023 | -$205.0M | -14.8% |
| FY2022 | -$178.5M | -19.8% |
| FY2021 | -$149.0M | -60.0% |
| FY2020 | -$93.2M | -252.2% |
| FY2019 | $61.2M | +209.4% |
| FY2018 | -$55.9M | -51.2% |
| FY2017 | -$37.0M | +54.7% |
| FY2016 | -$81.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice